Selected research
Market Structure
Global Radioisotopes in Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Radioisotopes in Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Radioisotopes in Medicine include ANSTO, China National Nuclear Corporation, Eckert & Ziegler Strahlen, IRE, Nordion, NorthStar Medical Radioisotopes, NRG, NTP Radioisotopes and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Radioisotopes in Medicine output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Radioisotopes in Medicine by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Radioisotopes in Medicine market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radioisotopes in Medicine and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radioisotopes in Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radioisotopes in Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Radioisotopes in Medicine Segment by Company
ANSTO
China National Nuclear Corporation
Eckert & Ziegler Strahlen
IRE
Nordion
NorthStar Medical Radioisotopes
NRG
NTP Radioisotopes
Polatom
Rosatom
SHINE Technologies
Radioisotopes in Medicine Segment by Type
Tc-99m
Iodine Radioisotopes
Cobalt-60
Others
Radioisotopes in Medicine Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Radioisotopes in Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioisotopes in Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radioisotopes in Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioisotopes in Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radioisotopes in Medicine market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radioisotopes in Medicine industry.
Chapter 3: Detailed analysis of Radioisotopes in Medicine market competition landscape. Including Radioisotopes in Medicine manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Radioisotopes in Medicine by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Radioisotopes in Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tc-99m
- Iodine Radioisotopes
- Cobalt-60
- Others
Applications
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
Companies covered
- ANSTO
- China National Nuclear Corporation
- Eckert & Ziegler Strahlen
- IRE
- Nordion
- NorthStar Medical Radioisotopes
- NRG
- NTP Radioisotopes
- Polatom
- Rosatom
- SHINE Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Radioisotopes in Medicine Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Radioisotopes in Medicine Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Radioisotopes in Medicine Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Radioisotopes in Medicine Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Radioisotopes in Medicine Market Dynamics
- 2.1 Radioisotopes in Medicine Industry Trends
- 2.2 Radioisotopes in Medicine Industry Drivers
- 2.3 Radioisotopes in Medicine Industry Opportunities and Challenges
- 2.4 Radioisotopes in Medicine Industry Restraints
3 Radioisotopes in Medicine Market by Manufacturers
- 3.1 Global Radioisotopes in Medicine Production Value by Manufacturers (2021-2026)
- 3.2 Global Radioisotopes in Medicine Production by Manufacturers (2021-2026)
- 3.3 Global Radioisotopes in Medicine Average Price by Manufacturers (2021-2026)
- 3.4 Global Radioisotopes in Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Radioisotopes in Medicine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Radioisotopes in Medicine Manufacturers, Product Type & Application
- 3.7 Global Radioisotopes in Medicine Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Radioisotopes in Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Radioisotopes in Medicine Players Market Share by Production Value in 2025
- 3.8.3 2025 Radioisotopes in Medicine Tier 1, Tier 2, and Tier 3
4 Radioisotopes in Medicine Market by Type
- 4.1 Radioisotopes in Medicine Type Introduction
- 4.1.1 Tc-99m
- 4.1.2 Iodine Radioisotopes
- 4.1.3 Cobalt-60
- 4.1.4 Others
- 4.2 Global Radioisotopes in Medicine Production by Type
- 4.2.1 Global Radioisotopes in Medicine Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radioisotopes in Medicine Production by Type (2021-2032)
- 4.2.3 Global Radioisotopes in Medicine Production Market Share by Type (2021-2032)
- 4.3 Global Radioisotopes in Medicine Production Value by Type
- 4.3.1 Global Radioisotopes in Medicine Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Radioisotopes in Medicine Production Value by Type (2021-2032)
- 4.3.3 Global Radioisotopes in Medicine Production Value Market Share by Type (2021-2032)
5 Radioisotopes in Medicine Market by Application
- 5.1 Radioisotopes in Medicine Application Introduction
- 5.1.1 Nuclear Therapy
- 5.1.2 Equipment Radioactive Source
- 5.1.3 Diagnosis
- 5.2 Global Radioisotopes in Medicine Production by Application
- 5.2.1 Global Radioisotopes in Medicine Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radioisotopes in Medicine Production by Application (2021-2032)
- 5.2.3 Global Radioisotopes in Medicine Production Market Share by Application (2021-2032)
- 5.3 Global Radioisotopes in Medicine Production Value by Application
- 5.3.1 Global Radioisotopes in Medicine Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Radioisotopes in Medicine Production Value by Application (2021-2032)
- 5.3.3 Global Radioisotopes in Medicine Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ANSTO
- 6.1.1 ANSTO Company Information
- 6.1.2 ANSTO Business Overview
- 6.1.3 ANSTO Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.1.4 ANSTO Radioisotopes in Medicine Product Portfolio
- 6.1.5 ANSTO Recent Developments
- 6.2 China National Nuclear Corporation
- 6.2.1 China National Nuclear Corporation Company Information
- 6.2.2 China National Nuclear Corporation Business Overview
- 6.2.3 China National Nuclear Corporation Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.2.4 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio
- 6.2.5 China National Nuclear Corporation Recent Developments
- 6.3 Eckert & Ziegler Strahlen
- 6.3.1 Eckert & Ziegler Strahlen Company Information
- 6.3.2 Eckert & Ziegler Strahlen Business Overview
- 6.3.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.3.4 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio
- 6.3.5 Eckert & Ziegler Strahlen Recent Developments
- 6.4 IRE
- 6.4.1 IRE Company Information
- 6.4.2 IRE Business Overview
- 6.4.3 IRE Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.4.4 IRE Radioisotopes in Medicine Product Portfolio
- 6.4.5 IRE Recent Developments
- 6.5 Nordion
- 6.5.1 Nordion Company Information
- 6.5.2 Nordion Business Overview
- 6.5.3 Nordion Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.5.4 Nordion Radioisotopes in Medicine Product Portfolio
- 6.5.5 Nordion Recent Developments
- 6.6 NorthStar Medical Radioisotopes
- 6.6.1 NorthStar Medical Radioisotopes Company Information
- 6.6.2 NorthStar Medical Radioisotopes Business Overview
- 6.6.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.6.4 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio
- 6.6.5 NorthStar Medical Radioisotopes Recent Developments
- 6.7 NRG
- 6.7.1 NRG Company Information
- 6.7.2 NRG Business Overview
- 6.7.3 NRG Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.7.4 NRG Radioisotopes in Medicine Product Portfolio
- 6.7.5 NRG Recent Developments
- 6.8 NTP Radioisotopes
- 6.8.1 NTP Radioisotopes Company Information
- 6.8.2 NTP Radioisotopes Business Overview
- 6.8.3 NTP Radioisotopes Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.8.4 NTP Radioisotopes Radioisotopes in Medicine Product Portfolio
- 6.8.5 NTP Radioisotopes Recent Developments
- 6.9 Polatom
- 6.9.1 Polatom Company Information
- 6.9.2 Polatom Business Overview
- 6.9.3 Polatom Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.9.4 Polatom Radioisotopes in Medicine Product Portfolio
- 6.9.5 Polatom Recent Developments
- 6.10 Rosatom
- 6.10.1 Rosatom Company Information
- 6.10.2 Rosatom Business Overview
- 6.10.3 Rosatom Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.10.4 Rosatom Radioisotopes in Medicine Product Portfolio
- 6.10.5 Rosatom Recent Developments
- 6.11 SHINE Technologies
- 6.11.1 SHINE Technologies Company Information
- 6.11.2 SHINE Technologies Business Overview
- 6.11.3 SHINE Technologies Radioisotopes in Medicine Production, Value and Gross Margin (2021-2026)
- 6.11.4 SHINE Technologies Radioisotopes in Medicine Product Portfolio
- 6.11.5 SHINE Technologies Recent Developments
7 Global Radioisotopes in Medicine Production by Region
- 7.1 Global Radioisotopes in Medicine Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Radioisotopes in Medicine Production by Region (2021-2032)
- 7.2.1 Global Radioisotopes in Medicine Production by Region (2021-2026)
- 7.2.2 Global Radioisotopes in Medicine Production Forecast by Region (2027-2032)
- 7.3 Global Radioisotopes in Medicine Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Radioisotopes in Medicine Production Value by Region (2021-2032)
- 7.4.1 Global Radioisotopes in Medicine Production Value by Region (2021-2026)
- 7.4.2 Global Radioisotopes in Medicine Production Value by Region (2027-2032)
- 7.5 Global Radioisotopes in Medicine Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Radioisotopes in Medicine Production Value (2021-2032)
- 7.6.2 Europe Radioisotopes in Medicine Production Value (2021-2032)
- 7.6.3 Asia-Pacific Radioisotopes in Medicine Production Value (2021-2032)
- 7.6.4 South America Radioisotopes in Medicine Production Value (2021-2032)
- 7.6.5 Middle East & Africa Radioisotopes in Medicine Production Value (2021-2032)
8 Global Radioisotopes in Medicine Consumption by Region
- 8.1 Global Radioisotopes in Medicine Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Radioisotopes in Medicine Consumption by Region (2021-2032)
- 8.2.1 Global Radioisotopes in Medicine Consumption by Region (2021-2026)
- 8.2.2 Global Radioisotopes in Medicine Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Radioisotopes in Medicine Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Radioisotopes in Medicine Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Radioisotopes in Medicine Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Radioisotopes in Medicine Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Radioisotopes in Medicine Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Radioisotopes in Medicine Value Chain Analysis
- 9.1.1 Radioisotopes in Medicine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Radioisotopes in Medicine Production Mode & Process
- 9.2 Radioisotopes in Medicine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Radioisotopes in Medicine Distributors
- 9.2.3 Radioisotopes in Medicine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst